Newron Pharmaceuticals Completes Enrollment for Pioneering Schizophrenia Drug Trial

4 Likes

“He highlighted that only 10% of schizophrenia patients are ever gainfully employed and that the condition lowers life expectancy by 30%”.

Dam.

3 Likes

It seems that there are many new treatments coming this year. For both positive and negative and cognitive symptoms. Let’s have hope, I trust that we are going to get out of this nightmare.

7 Likes